Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Clinical Microbiology Reviews

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/CMR.12.2.351PMID 10194463PMCID PMC88921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of Hepatitis B Immune Globulin for Prevention of Perinatal Transmission of the Hepatitis B Virus Carrier State: Final Report of a Randomized Double‐Blind, Placebo‐Controlled Trial

  2007cited by this paper
• Analysis of Liver Disease, Nuclear HBcAg, Viral Replication, and Hepatitis B Virus DNA in Liver and Serum of HBcAg Vs. Anti‐HBe Positive Carriers of Hepatitis B Virus

  2007cited by this paper
• Serodiagnosis of Recent Hepatitis B Infection by IgM Class Anti‐HBc

  2007cited by this paper
• Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.

  1998cited by this paper
• Progress toward elimination of hepatitis B virus transmission in the United States.

  1998cited by this paper
• Hepatitis B virus infection.

  1998cited by this paper
• Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States.

  1997cited by this paper
• The treatment of chronic viral hepatitis.

  1997cited by this paper
• Cytotoxic T cells and viral hepatitis.

  1997cited by this paper
• Hepatitis B vaccination and hepatocellular carcinoma in Taiwan.

  1997cited by this paper
• Long term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers

  1997cited by this paper
• The molecular medicine of viral hepatitis

  1997cited by this paper
• Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

  1997cited by this paper
• Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study.

  1997cited by this paper
• Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination.

  1996cited by this paper
• Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control.

  1996cited by this paper
• Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.

  1996cited by this paper
• Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan.

  1996influential reference
• Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.

  1995cited by this paper
• Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia.

  1995cited by this paper
• Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen.

  1995cited by this paper
• Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.

  1995cited by this paper
• Risks of chronicity following acute hepatitis B virus infection: a review.

  1995cited by this paper
• Long-Term Efficacy Of Active Postexposure Immunization Of Infants For Prevention Of Hepatitis B Virus Infection

  1995cited by this paper
• The structure of hepatitis B envelope and molecular variants of hepatitis B virus

  1995cited by this paper
• A preliminary trial of lamivudine for chronic hepatitis B infection.

  1995cited by this paper
• Hepatitis B virus immunopathogenesis.

  1995cited by this paper
• Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults.

  1995cited by this paper
• Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B.

  1995cited by this paper
• A 5-year immunization field trial against hepatitis B using a Chinese hamster ovary cell recombinant vaccine in French Polynesian newborns: results at 3 years.

  1994cited by this paper
• Twelve-year follow-up study of hepatitis B immunization of Senegalese infants.

  1994cited by this paper
• Prostaglandin E plus famciclovir--a new concept for the treatment of severe hepatitis B after liver transplantation.

  1994cited by this paper
• Genetic and Biological Characterization of Two Hepatitis B Virus Variants: A Precore Mutant Implicated in Fulminant Hepatitis and a Surface Mutant Resistant to Immunoprophylaxis

  1994cited by this paper
• Treatment of chronic viral hepatitis.

  1994cited by this paper
• Mutations in S region of hepatitis B virus.

  1994cited by this paper
• Adoption of a new Haemophilus influenzae type b vaccine recommendation.

  1993cited by this paper
• Washington Perspective: Mounting opposition to managed competition

  1993cited by this paper
• Studies on the attachment and penetration of hepatitis B virus.

  1993cited by this paper
• Molecular virology and pathogenesis of hepatitis B.

  1993cited by this paper
• Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early?

  1993cited by this paper
• Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection.

  1993cited by this paper
• Long-term follow-up of chronic hepatitis B patients treated with interferon alfa.

  1993cited by this paper
• Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.

  1993cited by this paper
• Molecular virology and pathogenesis of hepatitis B

  1993cited by this paper
• Hepatitis B vaccine responsiveness in Connecticut public safety personnel.

  1993cited by this paper
• Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination vaccine formulations.

  1993cited by this paper
• Reactions of pediatricians to a new Centers for Disease Control recommendation for universal immunization of infants with hepatitis B vaccine.

  1993cited by this paper
• A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates.

  1993cited by this paper
• Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.

  1993cited by this paper
• Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

  1993cited by this paper
• Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody—treated liver transplant patients

  1992cited by this paper
• Hepatitis B immunization: vaccine types, efficacy, and indications for immunization.

  1992cited by this paper
• Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study.

  1992cited by this paper
• Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years.

  1992cited by this paper
• Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection.

  1992cited by this paper
• Hepatitis B vaccination in children: five year booster study.

  1992cited by this paper
• Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees.

  1992cited by this paper
• Horizontal transmission of hepatitis B virus infection.

  1992cited by this paper
• Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device.

  1992cited by this paper
• Hepatitis B immunization: vaccine types, efficacy, and indications for immunization.

  1992cited by this paper
• Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers.

  1992cited by this paper
• Long-term remission of chronic hepatitis B after alpha-interferon therapy.

  1991cited by this paper
• Independent emergence of a vaccine-induced escape mutant of hepatitis B virus.

  1991cited by this paper
• Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.

  1991cited by this paper
• Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.

  1991cited by this paper
• Hepatitis B: Evolving Epidemiology and Implications for Control

  1991cited by this paper
• Serologic Diagnosis of Acute and Chronic Viral Hepatitis

  1991cited by this paper
• Hepatitis B virus.

  1991cited by this paper
• The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen‐positive‐hepatitis B surface antigen carrier mothers

  1991cited by this paper
• Booster response to recombinant yeast-derived hepatitis B vaccine in vaccinees whose anti-HBs responses were initially elicited by a plasma-derived vaccine.

  1991cited by this paper
• Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.

  1990cited by this paper
• Physiology and function of the vero cell receptor for the hepatitis B virus small S protein.

  1990cited by this paper
• Hepatitis B virus eradication strategy for Asia. The Asian Regional Study Group.

  1990cited by this paper
• Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis.

  1990cited by this paper
• Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis.

  1990cited by this paper
• Vaccine-induced escape mutant of hepatitis B virus.

  1990cited by this paper
• The epidemiology of hepatitis B virus among family members in the Middle East.

  1990cited by this paper
• Binding of the major and large HBsAg to human hepatocytes and liver plasma membranes: Putative external and internal receptors for infection and secretion of hepatitis B virus

  1990cited by this paper
• Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification

  1990cited by this paper
• The role of the T cell receptor in positive and negative selection of developing T cells.

  1990cited by this paper
• Clinical experience with hepatitis B vaccines.

  1989cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine.

  1989cited by this paper
• Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980.

  1989cited by this paper
• Hepatitis B virus infection among children born in the United States to Southeast Asian refugees

  1989cited by this paper
• Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees.

  1989cited by this paper
• Effect of bicarbonate administration on cardiac function.

  1989cited by this paper
• Epidemiology of hepatitis B in the Gezira region of Sudan.

  1989cited by this paper
• Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.

  1989cited by this paper
• Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region

  1989cited by this paper
• Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.

  1989cited by this paper
• Increased serum cortisol binding in chronic active hepatitis.

  1989cited by this paper
• Long‐term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg‐positive HBsAg‐carrier mothers

  1988influential reference
• Maternal‐infant transmission of hepatitis B in Egypt

  1988cited by this paper
• Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine.

  1988cited by this paper
• Hepatitis B variant in Europe.

  1988cited by this paper
• Persistence of specific antibodies after hepatitis B vaccination.

  1988cited by this paper
• A longitudinal follow‐up of asymptomatic hepatitis B surface antigen‐positive chinese children

  1988cited by this paper
• NIH conference. Hepatocellular carcinoma.

  1988cited by this paper
• Hepatitis B virus. The major etiology of hepatocellular carcinoma

  1988cited by this paper

• Success of electrochemical immunosensors for the determination of hepatitis B surface antigen, an important clinical marker in the diagnosis of hepatitis B

  2026cites this paper
• Niveles de anticuerpos posinmunización contra el virus de la hepatitis B

  2025cites this paper
• Knowledge and Vaccination Coverage against Hepatitis B Virus (HBV) in Brazzaville Universities

  2025cites this paper
• Biochemical and Serological Investigations in Incidentally Detected Asymptomatic HBsAg-Positive Subjects (IDAHS)

  2025cites this paper
• Knowledge and occupational practices of beauticians and barbers in the transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana

  2025cites this paper
• Trends in drug repurposing for chronic hepatitis-B infection: Bibliometric-based approach 1990-2024

  2024cites this paper
• A New Approach in the Early Electrochemical Diagnosis of Hepatitis B Virus Infection using Carbon-based Nanomaterials.

  2024cites this paper
• Unravelling the mechanisms by which chronic hepatitis B infection is associated with an increased risk of gestational diabetes

  2023cites this paper
• Serological profile and interpretation of different hepatitis B virus marker

  2023cites this paper
• Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem

  2023cites this paper
• PREVALENCE OF HEPATITIS B VIRUS AND GENOTYPES IN THE REGION OF KHYBER PAKHTUNKHWA PAKISTAN

  2023cites this paper
• Polymorphism Analysis of Interleukin-18 and Interleukin-37 Genes in Hepatitis B Infections with Different Outcomes: A Preliminary Report from an Iranian Population

  2023cites this paper
• Assessment of the Effectiveness of Hepatitis B Vaccination among Vaccinated Infants after the first dose

  2023cites this paper
• Progress and Unfinished Business: Hepatitis B in the United States, 1980-2019.

  2023cites this paper
• A New Modeling of Fractional-Order and Sensitivity Analysis for Hepatitis-B Disease with Real Data

  2023cites this paper
• TREAT-B Algorithm for Treatment Eligibility Among Chronically Infected Hepatitis B Virus Persons in a Low and a High Endemic Region: A Potential Strategy Towards Virus Elimination by 2030

  2022cites this paper
• ASYMPTOMATIC HBV CARRIERS IN BABOL, IRAN

  2022cites this paper
• Occult Hepatitis B Virus: Implications in Endemic Region like Nigeria.

  2022cites this paper
• Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B

  2022cites this paper
• Post-vaccine immunity against hepatitis B in Moroccan children

  2022cites this paper
• Immune response against Hepatitis B vaccine in transfusion-dependent thalassemic children vaccinated in early infancy

  2022cites this paper
• Orientación técnica: manejo y tratamiento de la infección por virus de la hepatitis B (VHB) Chile, 3 Edición. 2021

  2022cites this paper
• Hepatitis B virus (HBV) serological patterns among the HBsAg negative hospital attendees screened for immunization

  2022cites this paper
• The Prevalence of Hepatitis B Virus Infection among Patients Attending Defence Headquarters Medical Centre, Asokoro, Abuja, Nigeria

  2022cites this paper
• Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment

  2022influential citation
• Hepatitis B surface Antigen II (HBsII) Atellica IM Analyzer

  2021cites this paper
• Advances and insights in the diagnosis of viral infections

  2021cites this paper
• Knowledge, awareness and practices related to Hepatitis-B infection and vaccine among general population in Chengalpattu, Tamil Nadu

  2021cites this paper
• Serological Features of Children Vertically Infected With Hepatitis B Virus: A Study in Amir Al-Momenin Ali Hospital of Zabol

  2021cites this paper
• Prevalence of Hepatitis B Virus Infection and Factors Associated with Hepatitis B Virus Infection Among Pregnant Women Presented to Antenatal Care Clinics at Adigrat General Hospital in Northern Ethiopia

  2021cites this paper
• Hepatitis B Virus Seroprevalence and Genetic Variants among HIV Infected Patients in Nyanza, Kenya

  2021cites this paper
• Prevalence and intensity of malaria infection and associated risk factors in Anambra State, Nigeria

  2021cites this paper
• Hepatitis B virus prevalence in first‐time blood donors in Flanders, Belgium: Impact of universal vaccination and migration

  2021cites this paper
• Viren mit doppelsträngigem DNA-Genom

  2021cites this paper
• Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.

  2020cites this paper
• Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection

  2020cites this paper
• Identification of Hepatitis B virus etiologic antigens, HBx and Pre-S2, in Diffuse Large B-cell Lymphoma.

  2020cites this paper
• Infectious diseases

  2020cites this paper
• Hepatitis B Virus (HBV): A Review on its Prevalence and Infection in different areas of Iraq

  2020influential citation
• Prevalence of Hepatitis B, C and Tuberculosis in Under Privileged Children (Orphans) of District Bagh, Azad Jammu and Kashmir

  2020influential citation
• When viruses collide: hepatitis B virus reactivation after hepatitis C treatment.

  2020influential citation
• Single hepatocytes show persistence and transcriptional inactivity of hepatitis B

  2020cites this paper
• Evaluation of Peginterferon alfa-2a Response Rate in HBe-Negative Chronic Hepatitis B: A Systematic Review and Meta-Analysis

  2020cites this paper
• Recent Advances in Data Science: Third International Conference on Data Science, Medicine, and Bioinformatics, IDMB 2019, Nanning, China, June 22–24, 2019, Revised Selected Papers

  2020cites this paper
• Clinical Implications of the Molecular Biology of Hepatitis B Virus

  2020cites this paper
• Polymorphism rs368234815 of interferon-λ4 gene and generation of antibodies to hepatitis B virus surface antigen in extracorporeal dialysis patients

  2020cites this paper
• Association between Iron Profile and Hepatitis B Viral Load in Sudanese Patients

  2020cites this paper
• Serosurvey of Hepatitis-B Surface Antigen in Afghan Refugees; the First Report from Qazvin, Iran

  2020cites this paper
• Risk factors for hepatitis b virus among blood donors in Baghdad, Iraq

  2019cites this paper
• A Changing Era in Chronic Hepatitis B: Novel Biomarkers and Therapies

  2019cites this paper
• تعیین وضعیت ایمنی در مقابل ویروس عامل هپاتیت B و فراوانی موارد مثبت HBsAg در کادر درمانی بیمارستان آموزشی ـ درمانی شهید بهشتی شهر یاسوج، سال 1395

  2019cites this paper
• Prevalence of Hepatitis B and C in District Dir Upper, Khyber Pakhtunkhwa, Pakistan

  2019cites this paper
• MB1_OA_Swetha 1 edit

  2019cites this paper
• Immune response of standard and delayed hepatitis B vaccination schedules among medical students – a cross sectional comparative study

  2019influential citation
• An ARMA Model for Short-term Prediction of Hepatitis B Virus Seropositivity among Blood Donors in Lafia-Nigeria

  2019cites this paper
• Seroprevalence of Hepatitis B Virus in Multitransfused Patients with Special Reference to Occult Hepatitis B Virus Infection

  2019cites this paper
• The knowledge and reported vaccination status of hepatitis B virus amongst medical students in a Nigerian tertiary teaching hospital

  2019cites this paper
• An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia

  2019cites this paper
• Association of PvuII and XbaI Polymorphisms in Estrogen Receptor Alpha (ESR1) Gene with the Chronic Hepatitis B Virus Infection

  2019cites this paper
• Prevalence of hepatitis B infections in local and incoming populations of the public health laboratory reviewers in Al- Nasiriyah city - Iraq

  2019cites this paper
• Prevalence and risk factors of hepatitis B virus infection in Middle‐Limburg Belgium, year 2017: Importance of migration

  2019cites this paper
• Hepatitis B virus infection: Epidemiology and seroprevalence rate amongst Negrito tribe in Malaysia.

  2019cites this paper
• Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Co-infection.

  2019cites this paper
• Polyphenols in the Management of Chronic Liver Diseases Including Hepatocellular Carcinoma

  2019cites this paper
• Seroprevalence of Australia antigen (HbsAg) among blood donors in local population

  2019cites this paper
• Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis

  2019cites this paper
• “B in IT” - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool

  2018cites this paper
• Evaluation of immune response to hepatitis B vaccine in healthcare workers at a tertiary care hospital

  2018cites this paper
• A Cross-Sectional Study for the Evaluation of Attitude, Awareness and Knowledge among Female Dental Undergraduates of Karachi about Hepatitis B and Human Immunodeficiency Viral Infections

  2018cites this paper
• 72 – Vaccines for Healthcare Personnel

  2018cites this paper
• Exploring New Therapies for a Serological Cure of Chronic Hepatitis B

  2018cites this paper
• Evaluation of ELISA and HBsAg Rapid Test Cassette Assay in Detection of Hepatitis B Virus

  2018cites this paper
• Prevalence of serum markers of infection and naturally acquired immunity to hepatitis B virus in transfused children treated at a children’s hospital in Salvador, Bahia: A cross-sectional study

  2018cites this paper
• Trend in Seroprevalence of Hepatitis B Virus Infection Among Blood Donors In A Tertiary Care Teaching Hospital In Tirupati

  2018cites this paper
• Molecular Detection of Hepatitis B Virus Genotypes Among Human Immunodeficiency Virus Patients in Khartoum State Sudan

  2018cites this paper
• Effects of curcumin on NF‐κB, AP‐1, and Wnt/β‐catenin signaling pathway in hepatitis B virus infection

  2018cites this paper
• The field effect transistor DNA biosensor based on ITO nanowires in label-free hepatitis B virus detecting compatible with CMOS technology.

  2018cites this paper
• FREQUENCY OF HEPATITIS B & C IN YOUNG MALE RECRUITS FROM RURAL PAKISTAN

  2018cites this paper
• Impact of hypoxia on hepatitis B virus replication

  2018cites this paper
• RISK FACTORS FOR HEPATITIS B AND C AMONG MILITARY RECRUITS

  2018cites this paper
• RISK FACTORS OF HEPATITIS B INFECTION AMONG PATIENTS IN A TERTIARY CARE SETTING IN KERALA

  2018cites this paper
• Spontaneous hepatitis B surface antigen seroconversion after long lasting hepatitis B virus infection in a chronic hemodialysis patient

  2018cites this paper
• SEROPREVALENCE OF HEPATITIS-B VIRUS IN KUMAUN REGION OF UTTARAKHAND

  2018cites this paper
• Factors influencing the uptake of hepatitis B vaccine among health care workers at Kenyatta National Hospital

  2018cites this paper
• Prevalence of Hepatitis C in General Population of District Swat, Khyber Pakhtoonkhwa, Pakistan

  2018cites this paper
• Knowledge, attitude and practices of teacher trainees On the prevention of hepatitis b virus infection in the Kumasi metropolis

  2018cites this paper
• Hepatitis A and B Infections.

  2017cites this paper
• Study of Hepatitis B Virus Infection in Pregnant women And Their Outcome

  2017cites this paper
• Seroprevalence and risk factors of hepatitis B virus among blood donors in district Charsadda Khyber Pakhtunkhwa Pakistan

  2017cites this paper
• Exploring circulating biomarkers in patients with hepatocellular cancer

  2017cites this paper
• Prevalence of Hepatitis B and C in Blood Bank Donors in SVNGMC Yavatmal

  2017cites this paper
• Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study.

  2017cites this paper
• Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.

  2017cites this paper
• Hepatitis B virus X protein impairs α‐interferon signaling via up‐regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A

  2017cites this paper
• SEROPREVALENCE OF HEPATITIS B SURFACE ANTIGEN IN A TERTIARY CARE HOSPITAL FROM CENTRAL INDIA - A FIVE-YEAR STUDY

  2017cites this paper
• HEPATITIS B STAGES OF DISEASE IN FIRST VISIT IN ALL DIFFERENT AGE GROUPS AT ASIAN INSTITUTE OF MEDICAL SCIENCE

  2017cites this paper
• Función renal en los pacientes con hepatopatía por virus C: Influencia en el tratamiento

  2017cites this paper
• High Prevalence of Hepatitis B Virus Infection in the Age Range of 20-39 Years Old Individuals in Lome

  2017cites this paper
• Assessment of hepatitis B in high risk people of Gachsaran city, Iran

  2017cites this paper
• 8-Hydroxy-2'-Deoxyguanosin in Peripheral Leukocyte Associated With HBsAg in Patients with Chronic Hepatitis B

  2017cites this paper